Anti-amyloidogenic and anti-apoptotic role of melatonin in alzheimer disease

Current Neuropharmacology

Volumn 8, Issue 3, 2010, Pages 211-217

  He, Hongwen ^a   Dong, Weiguo ^a   Huang, Fang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Alzheimer disease; Amyloid beta protein; Amyloid precursor protein; Apoptosis; Melatonin; Mitochondria; Neurodegeneration; Neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; INDOLEAMINE; MELATONIN; PRESENILIN;

AGE; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN; DEGENERATIVE DISEASE; GLIA CELL; HIPPOCAMPUS; HUMAN; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NONHUMAN; PINEAL BODY; SENILE PLAQUE; TRANSGENIC MOUSE;

EID: 78549290673     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015910792246137     Document Type: Article

References (133)

1. Albrecht, S., Bourdeau, M., Bennett, D., Mufson, E.J., Bhattacharjee,M., LeBlanc, A.C. (2007) Activation of caspase-6 in aging andmild cognitive impairment. Am. J. Pathol., 170, 1200-1209.
2. Alvarez, A., Alarcon, R., Opazo, C., Campos, E.O., Munoz, F.J., Calderon, F.H., Dajas, F., Gentry, M.K., Doctor, B.P., De Mello, F.G., Inestrosa, N.C. (1998) Stable complexes involving acetylcholinesteraseand amyloid-beta peptide change the biochemical propertiesof the enzyme and increase the neurotoxicity of Alzheimer'sfibrils. J. Neurosci., 18, 3213-3223.
3. Anderson, A.J., Pike, C.J., Cot, C.W. (1995) Differential inductionof immediate early gene proteins in cultured neurons bybeta-amyloid (A beta): association of c-Jun with A beta-inducedapoptosis. J. Neurochem., 65, 1487-1498.
4. Andrabi, S.A., Sayeed, I., Siemen, D., Wolf, G., Horn, T.F. (2004) Direct inhibition of the mitochondrial permeability transition pore:a possible mechanism responsible for anti-apoptotic effects ofmelatonin. FASEB J, 18, 869-871.
5. Anisimov, V.N., Popovich, I.G., Zabezhinski, M.A., Anisimov, S.V., Vesnushkin, G.M., Vinogradova, I.A. (2006) Melatonin as antioxidant,geroprotector and anticarcinogen. Biochim. Biophys. Acta,1757, 573-589.
6. Ankarcrona, M., Winblad, B. (2005) Biomarkers for apoptosis inAlzheimer's disease. Int. J. Geriatr. Psychiatry, 20, 101-105.
7. Ashkenazi, A., Dixit, V.M. (1998) Death receptors: signaling andmodulation. Science, 281, 1305-1308.
8. Behl, C. (2000) Apoptosis and Alzheimer's disease. J. Neural.Transm., 107, 1325-1344.
9. Calissano, P., Matrone, C., Amadoro, G. (2009) Apoptosis and in vitroAlzheimer disease neuronal models. Commun. Integr. Biol., 2, 163-169.
10. Chan, S.L., Griffin, W.S., Mattson, M.P. (1999) Evidence forcaspase-mediated cleavage of AMPA receptor subunits in neuronalapoptosis and Alzheimer's disease. J. Neurosci. Res., 57, 315-323.
11. Cheng, S., Ma, C., Qu, H., Fan, W., Pang, J., He, H. (2008) Differentialeffects of melatonin on hippocampal neurodegeneration indifferent aged accelerated senescence prone mouse-8. Neuro Endocrinol.Lett., 29, 91-99.
12. Copani, A., Sortino, M.A., Nicoletti, F., Giuffrida, S.A. (2002) Alzheimer's disease research enters a new cycle: how significant? Neurochem. Res., 27, 173-176.
13. Dahlgren, K.N., Manelli, A.M., Stine, W.B., Jr., Baker, L.K., Krafft, G.A., LaDu, M.J. (2002) Oligomeric and fibrillar species ofamyloid-beta peptides differentially affect neuronal viability. J.Biol. Chem., 277, 32046-32053.
14. Deng, Y.Q., Xu, G.G., Duan, P., Zhang, Q., Wang, J.Z. (2005) Effects of melatonin on wortmannin-induced tau hyperphosphorylation. Acta Pharmacol. Sin, 26, 519-526.
15. Dong, W., Huang, F., Fan, W., Cheng, S., Chen, Y., Zhang, W., Shi, H., He, H. (2010) Differential effects of melatonin on amyloidbetapeptide 25-35-induced mitochondrial dysfunction in hippocampalneurons at different stages of culture. J. Pineal Res., 48,117-125.
16. Drache, B., Diehl, G.E., Beyreuther, K., Perlmutter, L.S., Konig, G.(1997) Bcl-xl-specific antibody labels activated microglia associatedwith Alzheimer's disease and other pathological states. J. Neurosci.Res., 47, 98-108.
17. Dragunow, M., Faull, R.L., Lawlor, P., Beilharz, E.J., Singleton, K., Walker, E.B., Mee, E. (1995) In situ evidence for DNA fragmentationin Huntington's disease striatum and Alzheimer's diseasetemporal lobes. Neuroreport, 6, 1053-1057.
18. Esposito, E., Iacono, A., Muia, C., Crisafulli, C., Mattace Raso, G.,Bramanti, P., Meli, R., Cuzzocrea, S. (2008) Signal transductionpathways involved in protective effects of melatonin in C6 gliomacells. J. Pineal Res., 44, 78-87.
19. Feng, Z., Chang, Y., Cheng, Y., Zhang, B.L., Qu, Z.W., Qin, C., Zhang, J.T. (2004) Melatonin alleviates behavioral deficits associatedwith apoptosis and cholinergic system dysfunction in the APP695 transgenic mouse model of Alzheimer's disease. J. Pineal Res.,37, 129-136.
20. Feng, Z., Cheng, Y., Zhang, J.T. (2004) Long-term effects of melatoninor 17 beta-estradiol on improving spatial memory performancein cognitively impaired, ovariectomized adult rats. J. PinealRes., 37, 198-206.
21. Feng, Z., Qin, C., Chang, Y., Zhang, J.T. (2006) Early melatoninsupplementation alleviates oxidative stress in a transgenic mousemodel of Alzheimer's disease. Free Radic. Biol. Med., 40, 101-109.
22. Feng, Z., Zhang, J.T. (2004) Melatonin reduces amyloid betainducedapoptosis in pheochromocytoma (PC12) cells. J. PinealRes., 37, 257-266.
23. Feng, Z., Zhang, J.T. (2004) Protective effect of melatonin on betaamyloid-induced apoptosis in rat astroglioma C6 cells and itsmechanism. Free Radic. Biol. Med., 37, 1790-1801.
24. Forloni, G. (1996) Neurotoxicity of beta-amyloid and prion peptides. Curr. Opin. Neurol., 9, 492-500.
25. Fraser, P.E., Nguyen, J.T., Surewicz, W.K., Kirschner, D.A. (1991) pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys. J., 60, 1190-1201.
26. Giannakopoulos, P., Kovari, E., Savioz, A., de Bilbao, F., Dubois-Dauphin, M., Hof, P.R., Bouras, C. (1999) Differential distributionof presenilin-1, Bax, and Bcl-X(L) in Alzheimer's disease and frontotemporaldementia. Acta Neuropathol., 98, 141-149.
27. Golde, T.E., Eckman, C.B., Younkin, S.G. (2000) Biochemicaldetection of Abeta isoforms: implications for pathogenesis, diagnosis,and treatment of Alzheimer's disease. Biochim. Biophys. Acta,1502, 172-187.
28. Goldgaber, D., Lerman, M.I., McBride, O.W., Saffiotti, U., Gajdusek, D.C. (1987) Characterization and chromosomal localizationof a cDNA encoding brain amyloid of Alzheimer's disease. Science,235, 877-880.
29. Guo, Q., Fu, W., Xie, J., Luo, H., Sells, S.F., Geddes, J.W., Bondada, V., Rangnekar, V.M., Mattson, M.P. (1998) Par-4 is a mediatorof neuronal degeneration associated with the pathogenesis ofAlzheimer disease. Nat. Med., 4, 957-962.
30. Hardy, J., Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer'sdisease: progress and problems on the road to therapeutics. Science, 297, 353-356.
31. Hensley, K., Butterfield, D.A., Mattson, M., Aksenova, M., Harris, M., Wu, J.F., Floyd, R., Carney, J. (1995) A model for betaamyloidaggregation and neurotoxicity based on the free radicalgenerating capacity of the peptide: implications of molecularshrapnel for Alzheimer's disease. Proc. West Pharmacol. Soc., 38,113-120.
32. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L., Beyreuther, K. (1991) Aggregation and secondary structure of syntheticamyloid beta A4 peptides of Alzheimer's disease. J. Mol. Biol.,218, 149-163.
33. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science,274, 99-102.
34. Huang, T.H., Fraser, P.E., Chakrabartty, A. (1997) Fibrillogenesisof Alzheimer Abeta peptides studied by fluorescence energy transfer. J. Mol. Biol., 269, 214-224.
35. Inestrosa, N.C., Marzolo, M.P., Bonnefont, A.B. (1998) Cellularand molecular basis of estrogen's neuroprotection. Potential relevancefor Alzheimer's disease. Mol. Neurobiol., 17, 73-86.
36. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.J., Hama, E., Sekine-Aizawa, Y., Saido, T.C. (2000) Identification of the majorAbeta1-42-degrading catabolic pathway in brain parenchyma:suppression leads to biochemical and pathological deposition. Nat.Med., 6, 143-150.
37. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., Ihara, Y. (1994) Visualization of A beta 42(43) and A beta 40in senile plaques with end-specific A beta monoclonals: evidencethat an initially deposited species is A beta 42(43). Neuron, 13, 45-53.
38. Jang, M.H., Jung, S.B., Lee, M.H., Kim, C.J., Oh, Y.T., Kang, I., Kim, J., Kim, E.H. (2005) Melatonin attenuates amyloid beta25-35-induced apoptosis in mouse microglial BV2 cells. Neurosci. Lett.,380, 26-31.
39. Jesudason, E.P., Baben, B., Ashok, B.S., Masilamoni, J.G., Kirubagaran, R., Jebaraj, W.C., Jayakumar, R. (2007) Antiinflammatoryeffect of melatonin on A beta vaccination in mice. Mol. Cell Biochem., 298, 69-81.
40. Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Beyreuther, K., Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 proteinresembles a cell-surface receptor. Nature, 325, 733-736.
41. Kerr, J.F., Wyllie, A.H., Currie, A.R. (1972) Apoptosis: a basicbiological phenomenon with wide-ranging implications in tissuekinetics. Br. J. Cancer, 26, 239-257.
42. Kilic, U., Kilic, E., Reiter, R.J., Bassetti, C.L., Hermann, D.M.(2005) Signal transduction pathways involved in melatonininducedneuroprotection after focal cerebral ischemia in mice. J.Pineal Res., 38, 67-71.
43. Kitamura, Y., Shimohama, S., Kamoshima, W., Ota, T., Matsuoka, Y., Nomura, Y., Smith, M.A., Perry, G., Whitehouse, P.J., Taniguchi, T. (1998) Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer'sdisease. Brain Res., 780, 260-269.
44. Klunk, W.E., Panchalingam, K., McClure, R.J., Stanley, J.A., Pettegrew, J.W. (1998) Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4. Neurobiol. Aging, 19, 511-515.
45. Kostrzewa, R.M., Segura-Aguilar, J. (2003) Novel mechanisms andapproaches in the study of neurodegeneration and neuroprotection.a review. Neurotox. Res., 5, 375-383.
46. Lahiri, D.K. (1999) Melatonin affects the metabolism of the betaamyloidprecursor protein in different cell types. J. Pineal Res., 26,137-146.
47. Lahiri, D.K., Chen, D., Ge, Y.W., Bondy, S.C., Sharman, E.H.(2004) Dietary supplementation with melatonin reduces levels ofamyloid beta-peptides in the murine cerebral cortex. J. Pineal Res.,36, 224-231.
48. Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., Wisniewski, H.M. (1995) Cell death inAlzheimer's disease evaluated by DNA fragmentation in situ. ActaNeuropathol., 89, 35-41.
49. LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C., Hammond, J.(1999) Caspase-6 role in apoptosis of human neurons, amyloidogenesis,and Alzheimer's disease. J. Biol. Chem., 274, 23426-23436.
50. Lee, S.H., Chun, W., Kong, P.J., Han, J.A., Cho, B.P., Kwon, O.Y., Lee, H.J., Kim, S.S. (2006) Sustained activation of Akt bymelatonin contributes to the protection against kainic acid-inducedneuronal death in hippocampus. J. Pineal Res., 40, 79-85.
51. Leon, J., Acuna-Castroviejo, D., Escames, G., Tan, D.X., Reiter, R.J. (2005) Melatonin mitigates mitochondrial malfunction. J. PinealRes., 38, 1-9.
52. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.E., Jondro, P.D., Schmidt, S.D., Wang, K., et al. (1995) Candidate gene for the chromosome 1 familialAlzheimer's disease locus. Science, 269, 973-977.
53. Li, W.P., Chan, W.Y., Lai, H.W., Yew, D.T. (1997) TerminaldUTP nick end labeling (TUNEL) positive cells in the differentregions of the brain in normal aging and Alzheimer patients. J.Mol. Neurosci., 8, 75-82.
54. Li, X.C., Wang, Z.F., Zhang, J.X., Wang, Q., Wang, J.Z. (2005) Effect of melatonin on calyculin A-induced tau hyperphosphorylation.Eur. J. Pharmacol., 510, 25-30.
55. Liu, R.Y., Zhou, J.N., van Heerikhuize, J., Hofman, M.A., Swaab, D.F. (1999) Decreased melatonin levels in postmortem cerebrospinalfluid in relation to aging, Alzheimer's disease, and apolipoproteinE-epsilon4/4 genotype. J. Clin. Endocrinol. Metab., 84, 323-327.
56. Liu, S.J., Wang, J.Z. (2002) Alzheimer-like tau phosphorylationinduced by wortmannin in vivo and its attenuation by melatonin.Acta Pharmacol. Sin, 23, 183-187.
57. Lleo, A., Berezovska, O., Growdon, J.H., Hyman, B.T. (2004) Clinical, pathological, and biochemical spectrum of Alzheimer diseaseassociated with PS-1 mutations. Am. J. Geriatr. Psychiatry,12, 146-156.
58. Lorenzo, A., Yankner, B.A. (1994) Beta-amyloid neurotoxicityrequires fibril formation and is inhibited by congo red. Proc. Natl.Acad. Sci. USA, 91, 12243-12247.
59. Lucassen, P.J., Chung, W.C., Kamphorst, W., Swaab, D.F. (1997) DNA damage distribution in the human brain as shown by in situend labeling; area-specific differences in aging and Alzheimer diseasein the absence of apoptotic morphology. J. Neuropathol. Exp.Neurol., 56, 887-900.
60. MacGibbon, G.A., Lawlor, P.A., Sirimanne, E.S., Walton, M.R., Connor, B., Young, D., Williams, C., Gluckman, P., Faull, R.L., Hughes, P., Dragunow, M. (1997) Bax expression in mammalianneurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res., 750, 223-234.
61. Mahlberg, R., Walther, S., Kalus, P., Bohner, G., Haedel, S., Reischies, F.M., Kuhl, K.P., Hellweg, R., Kunz, D. (2008) Pineal calcificationin Alzheimer's disease: an in vivo study using computedtomography. Neurobiol. Aging, 29, 203-209.
62. Martin, M., Macias, M., Escames, G., Leon, J., Acuna-Castroviejo, D. (2000) Melatonin but not vitamins C and E maintains glutathionehomeostasis in t-butyl hydroperoxide-induced mitochondrialoxidative stress. FASEB J., 14, 1677-1679.
63. Matsubara, E., Bryant-Thomas, T., Pacheco Quinto, J., Henry, T.L., Poeggeler, B., Herbert, D., Cruz-Sanchez, F., Chyan, Y.J., Smith, M.A., Perry, G., Shoji, M., Abe, K., Leone, A., Grundke-Ikbal, I., Wilson, G.L., Ghiso, J., Williams, C., Refolo, L.M., Pappolla, M.A., Chain, D.G., Neria, E. (2003) Melatonin increasessurvival and inhibits oxidative and amyloid pathology in a transgenicmodel of Alzheimer's disease. J. Neurochem., 85, 1101-1108.
64. Mattson, M.P., Culmsee, C., Yu, Z.F. (2000) Apoptotic and antiapoptoticmechanisms in stroke. Cell Tissue Res., 301, 173-187.
65. Nagy, Z.S., Esiri, M.M. (1997) Apoptosis-related protein expressionin the hippocampus in Alzheimer's disease. Neurobiol. Aging,18, 565-571.
66. Nunan, J., Small, D.H. (2000) Regulation of APP cleavage byalpha-, beta-and gamma-secretases. FEBS Lett., 483, 6-10.
67. Olcese, J.M., Cao, C., Mori, T., Mamcarz, M.B., Maxwell, A., Runfeldt, M.J., Wang, L., Zhang, C., Lin, X., Zhang, G., Arendash,G. W. (2009) Protection against cognitive deficits and markers ofneurodegeneration by long-term oral administration of melatonin ina transgenic model of Alzheimer disease. J. Pineal Res., 47, 82-96.
68. Ono, K., Hasegawa, K., Yoshiike, Y., Takashima, A., Yamada, M., Naiki, H. (2002) Nordihydroguaiaretic acid potently breaks downpre-formed Alzheimer's beta-amyloid fibrils in vitro. J. Neurochem.,81, 434-440.
69. Ozcankaya, R., Delibas, N. (2002) Malondialdehyde, superoxidedismutase, melatonin, iron, copper, and zinc blood concentrationsin patients with Alzheimer disease: cross-sectional study. Croat.Med. J, 43, 28-32.
70. Pappolla, M., Bozner, P., Soto, C., Shao, H., Robakis, N.K., Zagorski, M., Frangione, B., Ghiso, J. (1998) Inhibition of Alzheimerbeta-fibrillogenesis by melatonin. J. Biol. Chem., 273, 7185-7188.
71. Pappolla, M.A., Chyan, Y.J., Poeggeler, B., Frangione, B., Wilson, G., Ghiso, J., Reiter, R.J. (2000) An assessment of the antioxidantand the antiamyloidogenic properties of melatonin: implications forAlzheimer's disease. J. Neural. Transm., 107, 203-231.
72. Pappolla, M.A., Ogden-Epker, M. (2000) Oxidative stress andthe amyloid conundrum. what is the connection? J. AlzheimersDis., 2, 79-82.
73. Pappolla, M.A., Simovich, M.J., Bryant-Thomas, T., Chyan, Y.J., Poeggeler, B., Dubocovich, M., Bick, R., Perry, G., Cruz-Sanchez, F., Smith, M.A. (2002) The neuroprotective activities of melatoninagainst the Alzheimer beta-protein are not mediated by melatoninmembrane receptors. J. Pineal Res., 32, 135-142.
74. Pappolla, M.A., Sos, M., Omar, R.A., Bick, R.J., Hickson-Bick, D.L., Reiter, R.J., Efthimiopoulos, S., Robakis, N.K. (1997) Melatoninprevents death of neuroblastoma cells exposed to the Alzheimeramyloid peptide. J. Neurosci., 17, 1683-1690.
75. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G., Cotman, C.W. (1993) Neurodegeneration induced by beta-amyloid peptidesin vitro: the role of peptide assembly state. J. Neurosci., 13, 1676-1687.
76. Poeggeler, B., Miravalle, L., Zagorski, M.G., Wisniewski, T., Chyan, Y.J., Zhang, Y., Shao, H., Bryant-Thomas, T., Vidal, R., Frangione, B., Ghiso, J., Pappolla, M.A. (2001) Melatonin reversesthe profibrillogenic activity of apolipoprotein E4 on the Alzheimeramyloid Abeta peptide. Biochemistry, 40, 14995-15001.
77. Pompl, P.N., Yemul, S., Xiang, Z., Ho, L., Haroutunian, V., Purohit, D., Mohs, R., Pasinetti, G.M. (2003) Caspase gene expressionin the brain as a function of the clinical progression of Alzheimerdisease. Arch. Neurol., 60, 369-376.
78. Price, D.L., Sisodia, S.S. (1998) Mutant genes in familial Alzheimer'sdisease and transgenic models. Annu. Rev. Neurosci., 21,479-505.
79. Puglielli, L., Tanzi, R.E., Kovacs, D.M. (2003) Alzheimer's disease:the cholesterol connection. Nat. Neurosci., 6, 345-351.
80. Quinn, J., Kulhanek, D., Nowlin, J., Jones, R., Pratico, D., Rokach, J., Stackman, R. (2005) Chronic melatonin therapy fails to alteramyloid burden or oxidative damage in old Tg2576 mice: implicationsfor clinical trials. Brain Res., 1037, 209-213.
81. Quinn, J., Montine, T., Morrow, J., Woodward, W.R., Kulhanek, D., Eckenstein, F. (2003) Inflammation and cerebral amyloidosisare disconnected in an animal model of Alzheimer's disease. J.Neuroimmunol., 137, 32-41.
82. Radogna, F., Cristofanon, S., Paternoster, L., D'Alessio, M., DeNicola, M., Cerella, C., Dicato, M., Diederich, M., Ghibelli, L.(2008) Melatonin antagonizes the intrinsic pathway of apoptosisvia mitochondrial targeting of Bcl-2. J. Pineal Res., 44, 316-325.
83. Reiter, R.J. (1992) The ageing pineal gland and its physiologicalconsequences. Bioessays, 14, 169-175.
84. Reiter, R.J., Richardson, B.A., Johnson, L.Y., Ferguson, B.N., Dinh, D.T. (1980) Pineal melatonin rhythm: reduction in aging Syrianhamsters. Science, 210, 1372-1373.
85. Robakis, N.K., Ramakrishna, N., Wolfe, G., Wisniewski, H.M.(1987) Molecular cloning and characterization of a cDNA encodingthe cerebrovascular and the neuritic plaque amyloid peptides. Proc.Natl. Acad Sci. USA, 84, 4190-4194.
86. Rohn, T.T., Head, E., Nesse, W.H., Cotman, C.W., Cribbs, D.H.(2001) Activation of caspase-8 in the Alzheimer's disease brain. Neurobiol. Dis., 8, 1006-1016.
87. Rohn, T.T., Rissman, R.A., Davis, M.C., Kim, Y.E., Cotman, C.W., Head, E. (2002) Caspase-9 activation and caspase cleavageof tau in the Alzheimer's disease brain. Neurobiol. Dis., 11, 341-354.
88. Sastre, M., Steiner, H., Fuchs, K., Capell, A., Multhaup, G., Condron, M.M., Teplow, D.B., Haass, C. (2001) Presenilin-dependentgamma-secretase processing of beta-amyloid precursor protein at asite corresponding to the S3 cleavage of Notch. EMBO Rep., 2,835-841.
89. Schubert, D., Chevion, M. (1995) The role of iron in beta amyloidtoxicity. Biochem. Biophys. Res. Commun., 216, 702-707.
90. Seiffert, D., Bradley, J.D., Rominger, C.M., Rominger, D.H., Yang, F., Meredith, J.E., Jr., Wang, Q., Roach, A.H., Thompson, L.A., Spitz, S.M., Higaki, J.N., Prakash, S.R., Combs, A.P., Copeland, R.A., Arneric, S.P., Hartig, P.R., Robertson, D.W., Cordell, B., Stern, A.M., Olson, R.E., Zaczek, R. (2000) Presenilin-1 and -2 aremolecular targets for gamma-secretase inhibitors. J. Biol. Chem.,275, 34086-34091.
91. Selkoe, D.J. (1998) The cell biology of beta-amyloid precursorprotein and presenilin in Alzheimer's disease. Trends Cell Biol., 8,447-453.
92. Selkoe, D.J. (1999) Translating cell biology into therapeutic advancesin Alzheimer's disease. Nature, 399, A23-31.
93. Serpell, L.C. (2000) Alzheimer's amyloid fibrils: structure andassembly. Biochim. Biophys. Acta, 1502, 16-30.
94. Shen, Y.X., Xu, S.Y., Wei, W., Wang, X.L., Wang, H., Sun, X.(2002) Melatonin blocks rat hippocampal neuronal apoptosisinduced by amyloid beta-peptide 25-35. J. Pineal Res., 32, 163-167.
95. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, L., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Pollinsky, R.L., Wasco, W., De Silva, H.A., Haines, J.L., Pericak-Vance, M.A., Tanzi, R.E., Roses, A., Fraser, P., Rommens, J.M., St. George-Hyslop, P. (1995) Cloning of a genebearing missense mutations in early-onset familial Alzheimer'sdisease. Nature (London) 375, 754-760.
96. Shimohama, S. (2000) Apoptosis in Alzheimer's disease--an update. Apoptosis, 5, 9-16.
97. Skribanek, Z., Balaspiri, L., Mak, M. (2001) Interaction betweensynthetic amyloid-beta-peptide (1-40) and its aggregation inhibitorsstudied by electrospray ionization mass spectrometry. J. MassSpectrom., 36, 1226-1229.
98. Smale, G., Nichols, N.R., Brady, D.R., Finch, C.E., Horton, W.E., Jr. (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol., 133, 225-230.
99. Song, W., Lahiri, D.K. (1997) Melatonin alters the metabolism ofthe beta-amyloid precursor protein in the neuroendocrine cell linePC12. J. Mol. Neurosci, 9, 75-92. of
100. Soto, C., Branes, M.C., Alvarez, J., Inestrosa, N.C. (1994) Structuraldeterminants the Alzheimer's amyloid beta-peptide. J. Neurochem.,63, 1191-1198.
101. Soto, C., Castano, E.M., Frangione, B., Inestrosa, N.C. (1995) Thealpha-helical to beta-strand transition in the amino-terminal fragmentof the amyloid beta-peptide modulates amyloid formation. J.Biol. Chem., 270, 3063-3067.
102. Soto, C., Sigurdsson, E.M., Morelli, L., Kumar, R.A., Castano, E.M., Frangione, B. (1998) Beta-sheet breaker peptides inhibit fibrillogenesisin a rat brain model of amyloidosis: implications forAlzheimer's therapy. Nat. Med., 4, 822-826.
103. Souetre, E., Salvati, E., Krebs, B., Belugou, J.L., Darcourt, G.(1989) Abnormal melatonin response to 5-methoxypsoralen in dementia. Am. J. Psychiatry, 146, 1037-1040.
104. Stadelmann, C., Deckwerth, T.L., Srinivasan, A., Bancher, C., Bruck, W., Jellinger, K., Lassmann, H. (1999) Activation ofcaspase-3 in single neurons and autophagic granules of granulovacuolardegeneration in Alzheimer's disease. Evidence for apoptoticcell death. Am. J. Pathol., 155, 1459-1466.
105. Su, J.H., Anderson, A.J., Cummings, B.J., Cotman, C.W. (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport, 5, 2529-2533.
106. Su, J.H., Deng, G., Cotman, C.W. (1997) Bax protein expression isincreased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J. Neuropathol. Exp.Neurol., 56, 86-93.
107. Sugaya, K., Reeves, M., McKinney, M. (1997) Topographic associationsbetween DNA fragmentation and Alzheimer's disease neuropathologyin the hippocampus. Neurochem. Int., 31, 275-281.
108. Tajes Orduna, M., Pelegri Gabalda, C., Vilaplana Hortensi, J., Pallas Lliberia, M., Camins Espuny, A. (2009) An evaluation of theneuroprotective effects of melatonin in an in vitro experimentalmodel of age-induced neuronal apoptosis. J. Pineal Res., 46, 262-267.
109. Tan, D.X., Chen, L.D., Poeggeler, B., Manchester, L., Reiter, R.J.(1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1, 57-60.
110. Tan, D.X., Hardeland, R., Manchester, L.C., Poeggeler, B., Lopez-Burillo, S., Mayo, J.C., Sainz, R.M., Reiter, R.J. (2003) Mechanisticand comparative studies of melatonin and classic antioxidants interms of their interactions with the ABTS cation radical. J. PinealRes., 34, 249-259.
111. Tanzi, R.E., Gusella, J.F., Watkins, P.C., Bruns, G.A., St George-Hyslop, P., Van Keuren, M.L., Patterson, D., Pagan, S., Kurnit, D.M., Neve, R.L. (1987) Amyloid beta protein gene: cDNA,mRNA distribution, and genetic linkage near the Alzheimer locus. Science, 235, 880-884.
112. Uetsuki, T., Takemoto, K., Nishimura, I., Okamoto, M., Niinobe, M., Momoi, T., Miura, M., Yoshikawa, K. (1999) Activation ofneuronal caspase-3 by intracellular accumulation of wild-type Alzheimeramyloid precursor protein. J. Neurosci., 19, 6955-6964.
113. Vardy, E.R., Catto, A.J., Hooper, N.M. (2005) Proteolytic mechanismsin amyloid-beta metabolism: therapeutic implications forAlzheimer's disease. Trends Mol. Med., 11, 464-472.
114. Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A.L., Curran, E., Burgess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G., Citron, M. (1999) Beta-secretase cleavage ofAlzheimer's amyloid precursor protein by the transmembraneaspartic protease BACE. Science, 286, 735-741.
115. Vila, M., Przedborski, S. (2003) Targeting programmed cell deathin neurodegenerative diseases. Nat. Rev. Neurosci., 4, 365-375.
116. Viswanath, V., Wu, Y., Boonplueang, R., Chen, S., Stevenson, F.F., Yantiri, F., Yang, L., Beal, M.F., Andersen, J.K. (2001) Caspase-9 activation results in downstream caspase-8 activationand bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineinducedParkinson's disease. J. Neurosci., 21, 9519-9528.
117. Wai, M.S., Liang, Y., Shi, C., Cho, E.Y., Kung, H.F., Yew, D.T.(2009) Co-localization of hyperphosphorylated tau and caspases inthe brainstem of Alzheimer's disease patients. Biogerontology, 10,457-469.
118. Wang, D.L., Ling, Z.Q., Cao, F.Y., Zhu, L.Q., Wang, J.Z. (2004) Melatonin attenuates isoproterenol-induced protein kinase A overactivationand tau hyperphosphorylation in rat brain. J. Pineal Res.,37, 11-16.
119. Wang, J.Z., Wang, Z.F. (2006) Role of melatonin in Alzheimer-likeneurodegeneration. Acta Pharmacol. Sin, 27, 41-49.
120. Wang, X. (2009) The antiapoptotic activity of melatonin in neurodegenerativediseases. CNS Neurosci. Ther., 15, 345-357.
121. Wang, X.C., Zhang, J., Yu, X., Han, L., Zhou, Z.T., Zhang, Y., Wang, J.Z. (2005) Prevention of isoproterenol-induced tauhyperphosphorylation by melatonin in the rat. Sheng Li XueBao, 57, 7-12.
122. Wang, X.C., Zhang, Y.C., Chatterjie, N., Grundke-Iqbal, I., Iqbal, K., Wang, J.Z. (2008) Effect of melatonin and melatonylvalpromideon beta-amyloid and neurofilaments in N2a cells. Neurochem.Res., 33, 1138-1144.
123. Weksler, M.E., Gouras, G., Relkin, N.R., Szabo, P. (2005) Theimmune system, amyloid-beta peptide, and Alzheimer's disease. Immunol. Rev., 205, 244-256.
124. Wogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., Rydel, R.E. (2005) Nucleation-dependent polymerization is an essentialcomponent of amyloid-mediated neuronal cell death. J.Neurosci., 25, 1071-1080.
125. Wu, Y.H., Swaab, D.F. (2005) The human pineal gland andmelatonin in aging and Alzheimer's disease. J. Pineal Res., 38,145-152.
126. Xing, Y., Higuchi, K. (2002) Amyloid fibril proteins. Mech AgeingDev., 123, 1625-1636.
127. Yang, F., Sun, X., Beech, W., Teter, B., Wu, S., Sigel, J., Vinters, H.V., Frautschy, S.A., Cole, G.M. (1998) Antibody to caspasecleavedactin detects apoptosis in differentiated neuroblastoma andplaque-associated neurons and microglia in Alzheimer's disease. Am. J. Pathol., 152, 379-389.
128. Yang, Y., Mufson, E.J., Herrup, K. (2003) Neuronal cell death ispreceded by cell cycle events at all stages of Alzheimer's disease. JNeurosci., 23, 2557-2563.
129. Yankner, B.A. (1996) Mechanisms of neuronal degeneration inAlzheimer's disease. Neuron, 16, 921-932.
130. Yao, M., Nguyen, T.V., Pike, C.J. (2005) Beta-amyloid-inducedneuronal apoptosis involves c-Jun N-terminal kinase-dependentdownregulation of Bcl-w. J. Neurosci., 25, 1149-1158.
131. Younkin, S.G. (1995) Evidence that A beta 42 is the real culprit inAlzheimer's disease. Ann. Neurol., 37, 287-288.
132. Zhang, Y.C., Wang, Z.F., Wang, Q., Wang, Y.P., Wang, J.Z.(2004) Melatonin attenuates beta-amyloid-induced inhibition ofneurofilament expression. Acta Pharmacol. Sin., 25, 447-451.
133. Zhou, J., Zhang, S., Zhao, X., Wei, T. (2008) Melatonin impairsNADPH oxidase assembly and decreases superoxide anion productionin microglia exposed to amyloid-beta1-42. J. Pineal Res., 45,157-165.